DNA imprinting defects associated with childhood osteosarcoma development and progression
1/27/2016
Children diagnosed with osteosarcoma may be impacted by a DNA imprinting defect also found in parents, according to new research from the Masonic Cancer Center, University of Minnesota.
Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to discover and characterise novel drug targets for myeloma using structural biology...
German team makes large computational gains in laser-driven radiation therapy of cancer
1/27/2016
Since lasers were first produced in the early 1960s, researchers have worked to apply laser technology from welding metal to surgeries, with laser technology advancing quickly through the last 50...
NICE issues guidance to the NHS for lynparzatm (olaparib)
1/27/2016
AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) has issued Technology Appraisal Guidance (TAG) for LYNPARZA® (olaparib), recommending it as a cost...
Expanding lung cancer screening to include people who quit smoking more than 15 years ago could detect more cases and further reduce associated mortality, according to a study1 by Mayo Clinic...
For breast cancer patients, never too late to quit smoking
1/27/2016
cancer, other respiratory disease, or cardiovascular disease than women who had never smoked.
Study identifies new class of anticancer compounds for possible targeted therapy in blood cancers
1/27/2016
A research team from the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute (RPCI) has discovered a new class of small-molecule compounds that are good candidates for...
NICE issues guidance to the NHS for lynparzatm (olaparib)
1/27/2016
AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) has issued Technology Appraisal Guidance (TAG) for LYNPARZA® (olaparib), recommending it as a cost...
Scientists discover new clue to how cancer tumors form
1/27/2016
Recordings of 3D movements in real time of early tumor formation reveal that specialized cancer cells extend cellular cables to actively reel in both cancerous and healthy cells.
Men and women in Appalachia continue to have higher cancer incidence rates compared with those in the rest of the United States regardless of race or location.